Affinivax, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2014-06-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.affinivax.com
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
Phase 1
Completed
- Conditions
- Healthy VolunteersPneumococcal Disease
- Interventions
- Biological: ASP3772Biological: PCV13
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Affinivax, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT04525599
- Locations
- 🇺🇸
Gentle Medicine Associates, Boynton Beach, Florida, United States
🇺🇸Ctr Clin Trials San Gabriel, West Covina, California, United States
🇺🇸Dermatology Trial Associates, Bryant, Arkansas, United States
Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Biological: PPSV23 (subcutaneous)Biological: ASP3772 (intramuscular)Biological: PPSV23 (intramuscular)Biological: ASP3772 (subcutaneous)
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Affinivax, Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT04265911
- Locations
- 🇯🇵
JP81001, Fukuoka, Japan
© Copyright 2025. All Rights Reserved by MedPath